Beijing, China

Zhongjun Li

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Zhongjun Li

Introduction

Zhongjun Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biochemistry and pharmaceuticals, holding a total of 4 patents. His work focuses on the development of innovative compounds with potential medical applications.

Latest Patents

Zhongjun Li's latest patents include a method for preparing a fucosylated chondroitin sulfate oligosaccharide. This oligosaccharide has a specific structure that allows it to be applied in the medical field. The preparation method involves using a chondroitin sulfate A salt as a raw material, followed by enzymolysis, group protection operations, and glycosylation to synthesize the oligosaccharide compound. Another notable patent involves the use of aza-tryptanthrin derivatives as inhibitors of IDO1 and/or TDO. These derivatives have shown inhibitory effects on indoleamine-2,3-dioxygenase 1 (IDO1) and can be utilized in treating various diseases, including tumors, autoimmune diseases, and Alzheimer's disease.

Career Highlights

Zhongjun Li has worked with esteemed institutions such as Peking University and Boe Technology Group Co., Ltd. His experience in these organizations has contributed to his expertise in the field of innovation and invention.

Collaborations

Zhongjun Li has collaborated with notable colleagues, including Xiangbao Meng and Jiliang Wang. Their joint efforts have further advanced research and development in their respective areas of expertise.

Conclusion

Zhongjun Li's innovative work and patents reflect his dedication to advancing medical science. His contributions have the potential to impact various therapeutic areas significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…